paraganglioma

Showing 1 - 25 of 33

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Fluorescence Guided Minimally-Invasive Resection Of Abdominal

Recruiting
  • Paraganglioma
  • Fluorescence guided identification using indocyanine green
  • Leiden, Netherlands
    Leiden University Medical Center
Dec 1, 2023

Neuroendocrine Tumors, Paraganglioma, Pheochromocytoma Trial (177Lu-DOTATOC)

Not yet recruiting
  • Neuroendocrine Tumors
  • +2 more
  • (no location specified)
Sep 13, 2023

F-18 FDOPA PET/CT Versus I-123 MIBG Scintigraphy With SPECT/CT

Terminated
  • Pheochromocytoma
  • Paraganglioma
  • F-18 FDOPA PET/CT
  • Seoul, Songpa-gu, Korea, Republic of
    Asan Medical Center
Jul 13, 2023

Pheochromocytoma, Paraganglioma Trial in Beijing (Temozolomide)

Recruiting
  • Pheochromocytoma
  • Paraganglioma
  • Beijing, China
    Peking Union Medical College Hospital
May 22, 2023

Pheochromocytoma, Paraganglioma Trial in Beijing (Anlotinib HCl)

Recruiting
  • Pheochromocytoma
  • Paraganglioma
  • Anlotinib hydrochloride
  • Beijing, China
    Peking Union Medical College Hospital
May 22, 2023

Pheochromocytoma, Paraganglioma, Adrenalectomy; Status Trial in Seoul (Phenoxybenzamine)

Recruiting
  • Pheochromocytoma
  • +3 more
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Jan 18, 2023

Pheochromocytoma, Paraganglioma, Neuroendocrine Tumors Trial run by the NCI (Lu-177-DOTATATE, Ga-68-DOTATATE, F-18-FDG)

Recruiting
  • Pheochromocytoma
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 19, 2023

Adrenal Gland Pheochromocytoma, Hematopoietic and Lymphoid System Tumor, Malignant Solid Tumor Trial run by the National Cancer

Recruiting
  • Adrenal Gland Pheochromocytoma
  • +3 more
  • Computed Tomography
  • +2 more
  • Bethesda, Maryland
  • +1 more
Jan 3, 2023

Pheochromocytoma, Paraganglioma Trial in Philadelphia ([18F]FluorThanatrace ([18F]FTT))

Not yet recruiting
  • Pheochromocytoma
  • Paraganglioma
  • [18F]FluorThanatrace ([18F]FTT)
  • Philadelphia, Pennsylvania
    Abramson Cancer Center of the University of Pennsylvania
Dec 1, 2022

Pheochromocytoma, Paraganglioma Trial in Marseille (Infrared themrography)

Recruiting
  • Pheochromocytoma
  • Paraganglioma
  • Infrared themrography
  • Marseille, Paca, France
    Pôle ENDO- Hopital la Conception APHM
Nov 12, 2022

DOTATOC PET/CT for Imaging NET Patients

Recruiting
  • Neuroendocrine Tumors
  • +15 more
  • 68Ga-DOTATOC PET/CT
  • 18F-FDG PET/CT
  • Vancouver, British Columbia, Canada
    BC Cancer
Nov 2, 2022

Pheochromocytoma, Paraganglioma Trial in New York (Axitinib)

Recruiting
  • Pheochromocytoma
  • Paraganglioma
  • New York, New York
    Columbia University Irving Medical Center
Oct 5, 2022

Paraganglioma, Pheochromocytoma Trial in New York, Cleveland (Lanreotide)

Recruiting
  • Paraganglioma
  • Pheochromocytoma
  • New York, New York
  • +1 more
Oct 5, 2022

68-Ga DOTATATE PET/MRI in Diagnosis and Management of

Recruiting
  • CNS Tumors
  • +6 more
  • Ga68-DOTATATE-PET/MRI
  • New York, New York
    Weill Cornell Medicine
Sep 20, 2022

Pheochromocytoma, Paraganglioma, Inherited Cancer Syndrome Trial in San Antonio (Genetic screening)

Recruiting
  • Pheochromocytoma
  • +7 more
  • Genetic screening
  • San Antonio, Texas
    University of Texas Health Science Center
Aug 25, 2022

Acinar Cell Carcinoma, Adenoid Cystic Carcinoma, Adrenal Cortical Carcinoma Trial in Guam, United States (Biospecimen

Recruiting
  • Acinar Cell Carcinoma
  • +93 more
  • Biospecimen Collection
  • +2 more
  • Birmingham, Alabama
  • +998 more
Aug 23, 2022

Dysglycemia in Pheochromocytoma and Paraganglioma

Active, not recruiting
  • Pheochromocytoma
  • Paraganglioma
  • Catecholamines
  • Beijing, Beijing, China
    Xian-Liang Zhou
Jul 9, 2022

Exendin PET/CT for Imaging of Paragangliomas

Recruiting
  • Paraganglioma
  • 68Ga-NODAGA-exendin-4 PET/CT
  • Nijmegen, Netherlands
    Radboud University Medical Center
Jun 13, 2022

Gastroenteropancreatic Neuroendocrine Tumors, Pheochromocytoma, Paraganglioma Trial in Worldwide (Lutetium [177Lu]

Recruiting
  • Gastroenteropancreatic Neuroendocrine Tumors
  • +2 more
  • Lutetium [177Lu] oxodotreotide/dotatate
  • Iowa City, Iowa
  • +16 more
Apr 6, 2022

Neuroendocrine Tumor, Anaplastic Thyroid Cancer, Adenocarcinoma Trial in Spain (Cabozantinib 40 mg)

Recruiting
  • Neuroendocrine Tumor
  • +4 more
  • Cabozantinib 40 mg
  • Badalona, Barcelona, Spain
  • +14 more
Feb 15, 2022

Pheochromocytoma, Paraganglioma, Cardiovascular Morbidity Trial in Lucknow (Observational study)

Completed
  • Pheochromocytoma
  • +2 more
  • Observational study
  • Lucknow, Uttar Pradesh, India
    Sanjay Gandhi Postgraduate Institute of Medical Sciences
Feb 9, 2022

Prognostic's Factors of Head and Neck Paragangliomas Evolution

Not yet recruiting
  • Paraganglioma
  • Characterization of a population with cervical paragangliomas
  • Bron, France
    Fédération d'endocrinologie Hôpital Cardiologique/Groupement Hos
Jan 31, 2022

Development ofTele-monitoring Program for Patients Undergoing

Recruiting
  • Pheochromocytoma
  • Paraganglioma
  • Use of an internet plateform
  • Paris, France
    Hopital européen Georges Pompidou
Jan 17, 2022

Adrenocortical Carcinoma, Pheochromocytoma, Paraganglioma Trial in Worldwide (EO2401)

Recruiting
  • Adrenocortical Carcinoma
  • +2 more
  • EO2401
  • Houston, Texas
  • +9 more
Dec 7, 2021